S100A12 and COVID-19: Serum S100A12 had an area under the receiver operating characteristic curve (AUROC) for predicting severe compared to moderate COVID-19 of 0.643 (p = 0.006), indicating that it is not an excellent marker for assessing disease severity (Figure 1b).